Rachel Rimsky Rubin

Overview

Rachel Rimsky Rubin serves as Chief Operating Officer at Adelphi Data, a position Rubin has held since August 2024[1][2]. Prior to joining Adelphi Data, Rubin held the role of Chief Operating Officer at Oviva Therapeutics from September 2023 to July 2024[3]. Rubin's earlier experience includes positions at Roivant Sciences, where Rubin served as Vice President of Roivant Social Ventures from May 2021 to November 2022[4] and as Principal of Roivant Health from August 2017 to May 2021[5]. Rubin's background in finance includes roles at Goldman Sachs Asset Management as Vice President of Hedge Fund Strategies from June 2010 to August 2015[6], as well as positions at GAM and Deutsche Bank in fund of hedge funds analysis[7][8]. Rubin holds a Bachelor of Science degree in Industrial and Labor Relations from Cornell University, earned between 2003 and 2007[9].

Career history

1. Chief Operating OfficerAug 2024 to presentAdelphi Data
2. OTChief Operating OfficerSep 2023 to Jul 2024Oviva Therapeutics
3. Vice President, Roivant Social VenturesMay 2021 to Nov 2022Roivant Sciences
4. Principal, Roivant HealthAug 2017 to May 2021Roivant Sciences
5. GSVice President, Hedge Fund StrategiesJun 2010 to Aug 2015Goldman Sachs Asset Management
6. GAnalyst, Fund of Hedge FundsJun 2009 to Jun 2010GAM
7. Analyst, Fund of Hedge FundsMay 2008 to Feb 2009Deutsche Bank

Education

1. BS, Industrial and Labor Relations2003 - 2007Cornell University